Merck can say that Gardasil contains ‘no viral DNA’ all they want, but Dr. Sin Hang Lee had reported to the FDA just over two years ago that the vaccine contains fragments of DNA that shouldn’t be in something we give young women – so why is Gardasil still on the market?
After conducting extensive research, Dr. Lee found that in 100% of lab samples tested, fragments of HPV-11, HPV-16, and HPV-18 L1 DNA firmly attached to Merck’s proprietary aluminum adjuvant.
Even though SaneVax Inc reported their findings to the FDA, the controversial vaccine used to treat cervical cancer is still being sold, and the FDA states that ‘these fragments pose no health risk.’ Once again, the FDA has ignored science which proves that a drug created by a big pharmaceutical company is less than safe.
Dr. Lee also found that the HPV DNA fragments were not only bound to Merck’s proprietary aluminum adjuvant, but they had also adopted a non-B conformation, thereby creating a novel (new) chemical compound of unknown toxicity.
Furthermore, Non-B DNA conformations are known through Dr. Lee’s research to be associated with genetic abnormalities, as well as mutations which cause 70 serious diseases in human beings. Among them:
- Follicular lymphomas
- Polycystic kidney disease
- Spermatogenic failure
The FDA clearly should have investigated these claims by now, and at last put a temporary moratorium on Gardasil. But instead, the organization ignores the obvious possibility that Gardasil, as many have suspected, cause infertility problems and possibly even forms of cancer -the very disease that Gardasil is supposed to protect women against.
Instead of researching the possibility that the HPV vaccine was harming women, government officials and HPV vaccine supporters have been eager to discredit Dr. Lee’s research.
Fortunately, some industrious and intelligent people have come to Dr. Lee’s aid. Helen Petousis-Harris PhD, the Director of Immunisation Research and Vaccinology Immunisation Advisory Centre at The University of Auckland, gave a a public hearing on HPV vaccine safety in February 2014, in which she outlined the tactics of these agencies (through her own criticism) to discredit scientists that offer opposing facts to the Big Pharma propaganda line.
She argued that:
- Dr. Lee’s tests were over-sensitive. (Interesting – if findings go a deeper level than the cursory three-week toxicity trials, they are considered aberrant).
- No one else has replicated Dr. Lee’s findings. This is likely untrue, and what is more probable is that no one has been able to bring similar findings to the surface..
But, both of these ‘concerns’ were put to rest via data presented by Laurent Bélec at the 9th International Congress on Autoimmunity on March 26-30, 2014 in Nice, France. They published their findings in a paper titled, “Confirmation of the Creation of a Novel Molecule in Gardasil.”
“. . .Human papillomavirus (HPV) infection causes cervical cancer, a significant portion of anal, genital and oropharyngeal cancers, genital warts and recurrent respiratory papillomatosis. In June 2006, a prophylactic HPV vaccine (Gardasil®; Merck, NJ, USA) was licensed in the USA, with subsequent approval granted in the European Union. Gardasil® is a quadrivalent HPV protein-based vaccine containing genotype-specific L1 capsid proteins of HPV-16, HPV-18, HPV-6 and HPV-11 in the form of virus-like particles as the active ingredient, which are produced by a DNA recombinant technology in yeast.
Recently Lee SH showed that Gardasil® contained fragments of HPV-11 or HPV-18 DNA, evidenced by nested PCR, of unknown significance [J Inorg Biochem. 2012 Dec;117:85-92]. We herein looked by optimized single PCR in different batches of Gardasil® from France for HPV L1 DNA using MY09/MY11 degenerate and nondegenerate primers, for HPV E2 and E6 DNA genes, and for contaminating Saccharomyces cerevisiae DNA.
All amplified amplicons were sequenced and resulting FASTA sequences were analyzed by Genotyping software from NCBI. In-house quantitative single PCR using as external calibrator serial dilutions of HPV-16 DNA extracted from CaSki cell line allowed estimating the load of residual HPV DNA fragments in vaccine ampoules.
Preliminary data showed the presence of contaminating HPV L1 DNA in all tested different batches of Gardasil® vaccine from France. Our observations confirm independently and extend the previous observations by Lee SH, without using conflicting nested PCR detection possibly subjected to contamination. Persistence in muscle tissue of residual HPV DNA
Not only has another independent laboratory confirmed the findings of Dr. Lee in every Gardasil sample tested from France, this lab used a different and less ‘sensitive’ methodology to arrive at the same conclusion regarding Gardasil recombinant (genetically engineered) HPV DNA fragment contamination.
L. Belec1, H. Péré1, C. Fayard1.
1Microbiologie, Université Paris Descartes, Paris, France.”
Dr. Lee and Prof. Bélec and the SaneVax team indicate the need for further investigation for vaccine safety. Without even this minimum standard for vaccines, why should we trust the makers of the drugs or the agencies which allow for their distribution at all?